What is Green Bioactives?
Founded in 2018, Green Bioactives operates at the intersection of advanced biotechnology and sustainable manufacturing. The company specializes in the identification and extraction of plant-derived bioactive compounds, providing a reliable and environmentally conscious alternative to synthetic ingredients. Its core value proposition lies in its ability to serve diverse, high-barrier markets, including the cosmetic, pharmaceutical, food, and agricultural industries. By optimizing the natural chemical profiles of plants, Green Bioactives enables its partners to enhance product performance while adhering to increasingly stringent sustainability mandates. The company's research-heavy approach ensures that its bioactive solutions are not only effective but also scalable for industrial-level integration.
How much funding has Green Bioactives raised?
Green Bioactives has raised a total of $3.2M across 1 funding round:
Angel/Seed
$3.2M
Angel/Seed (2022): $3.2M with participation from Agtech Fund, Eos Advisory Partners, Scottish Enterprise, and Milltrust International Group
Key Investors in Green Bioactives
Eos Advisory Partners
Eos Advisory Partners provides specialized business consulting and financial advisory services, focusing on strategic challenges and capital markets support for growing enterprises.
Scottish Enterprise
Scottish Enterprise is a national economic development agency of the Scottish Government, dedicated to fostering innovation and sustainable economic growth within the region.
Milltrust International Group
Milltrust International Group is a specialist investment firm focused on sustainable solutions, addressing global themes such as food security, climate change, and emerging technology.
What's next for Green Bioactives?
With the recent infusion of capital, Green Bioactives is poised to accelerate its operational scaling and market penetration. The strategic roadmap likely involves expanding its laboratory infrastructure to increase the throughput of its bioactive extraction processes and strengthening its intellectual property portfolio. Furthermore, the company is expected to deepen its engagement with multinational partners in the pharmaceutical and cosmetic sectors, where the demand for clean-label, plant-based ingredients continues to outpace traditional supply. As the firm matures, the focus will shift toward optimizing supply chain logistics and securing regulatory approvals for new compound applications, ensuring that its sustainable technology becomes a standard component in global product development cycles.
See full Green Bioactives company page
